Katja Taxis

Prof. Dr. Katja Taxis

orcid

Research Focus & Metrics

Academic Career Length

28Years (1999-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
29 March 2003 in BMJ
Verified
Journal Article
Closed access
PDF file
KTKatja Taxis
Katja Taxis
NBNick Barber
Nick Barber
Objectives: To determine the incidence and clinical importance of errors in the preparation and administration of intravenous drugs and the stages of the process in which errors occur. Design: Prospective ethnographic study using disguised observation. Participants: Nurses who prepared and administered intravenous drugs. Setting: 10 wards in a teaching and non-teaching hospital in the United Kingdom. Main outcome measures: Number, type, and clinical importance of errors. Results: 249 errors were identified. At least one error occurred in 212 out of 430 intravenous drug doses (49%, 95% confidence interval 45% to 54%). Three doses (1%) had potentially severe errors, 126 (29%) potentially moderate errors, and 83 (19%) potentially minor errors. Most errors occurred when giving bolus doses or making up drugs that required multiple step preparation. Conclusions: The rate of intravenous drug errors was high. Although most errors would cause only short term adverse effects, a few could have been serious. A combination of reducing the amount of preparation on the ward, training, and technology to administer slow bolus doses would probably have the greatest effect on error rates. What is already known on this topic: Errors in preparing and administering intravenous drugs can cause considerable harm to patients Reduction of drug errors is a government health target in the United Kingdom and the United States What this study adds: Errors occurred in about half of the intravenous drug doses observed Errors were potentially harmful in about a third of cases The most common errors were giving bolus doses too quickly and mistakes in preparing drugs that required multiple steps

1 October 2003 in Quality and Safety in Health Care
Verified
Journal Article
Open access
PDF file
KTKatja Taxis
Katja Taxis
NBN Barber
N Barber
Background: Intravenous (IV) medication errors are frequent events. They are associated with considerable harm, but little is known about their causes. Human error theory is increasingly used to understand adverse events in medicine, but has not yet been applied to study IV errors. Our aim was to investigate causes of errors in IV drug preparation and administration using a framework of human error theory. Methods: A trained and experienced observer accompanied nurses during IV drug rounds on 10 wards in two hospitals (one university teaching hospital and one non-teaching hospital) in the UK. Information came from observation and talking informally to staff. Human error theory was used to analyse the causes of IV error. Results: 265 IV drug errors were identified during observation of 483 drug preparations and 447 administrations. The most common type of error was the deliberate violation of guidelines when injecting bolus doses faster than the recommended speed of 3–5 minutes. Causes included a lack of perceived risk, poor role models, and available technology. Mistakes occurred when drug preparation or administration involved uncommon procedures such as the preparation of very small volumes or the use of unusual drug vial presentations. Causes included a lack of knowledge of preparation or administration procedures and complex design of equipment. Underlying problems were the cultural context allowing unsafe drug use, the failure to teach practical aspects of drug handling, and design failures. Conclusions: Training needs and design issues should be addressed to reduce the rate of IV drug preparation and administration errors. This needs a coordinated approach from practitioners, regulators, and the pharmaceutical industry.

1 September 2012 in Journal of Affective Disorders
Verified
Journal Article
Closed access
ILIrene M. Lako
Irene M. Lako
RBR. Bruggeman
R. Bruggeman
HKH. Knegtering
H. Knegtering
DWD. Wiersma
D. Wiersma
RSR.A. Schoevers
R.A. Schoevers
KTKatja Taxis
Katja Taxis

1 January 2004 in European Journal of Clinical Pharmacology
Verified
Journal Article
Closed access
PDF file
NBN. Barber
N. Barber
KTKatja Taxis
Katja Taxis

1 October 2013 in Journal of Clinical Psychopharmacology
Verified
Journal Article
Closed access
ILIrene M. Lako
Irene M. Lako
EHEdwin R. van Den Heuvel
Edwin R. van Den Heuvel
HKHenrikus Knegtering
Henrikus Knegtering
RBRichard Bruggeman
Richard Bruggeman
KTKatja Taxis
Katja Taxis
Dose equivalents based on dopamine D₂ receptor occupancy can be used to compare antipsychotics on D₂ receptor-mediated (adverse) effects such as extrapyramidal symptoms and altered emotional experiences. Previous meta-analyses modeling the dose-occupancy relationship hardly addressed potential heterogeneity of the imaging data. To model the relationship between dose and D₂ receptor occupancy for a series of frequently prescribed antipsychotics while addressing the potential heterogeneity of the imaging data. We conducted a meta-analysis on published D₂ receptor occupancy data (positron emission tomography and single-photon emission computed tomography) in patients with schizophrenia treated with antipsychotics. A nonlinear mixed effects model estimated the median D₂ receptor occupancy for a given antipsychotic dose. Heterogeneity between studies was investigated by incorporating study as a random effect in the model, in addition to patient- and study-specific explanatory variables. Included were 51 studies, describing 606 patients (mean ± SD age, 32.2 ±10.8 years; 25.7% female). The models described the dose-occupancy relationship with narrow confidence bands around the therapeutic dose range. Maximum occupancy (95% confidence interval[CI]) was estimated for haloperidol (91.9%; 95% CI, 86.1-97.8), risperidone(92.4%; 95% CI, 81.8-100), olanzapine (96.5%; 95% CI,85.8-100), clozapine (61.7%; 95% CI, 49.2-74.2), quetiapine (49.1%; 95% CI, 18.7-79.6), aripiprazole (86.9%; 95% CI, 78.2-95.7), ziprasidone (82.9%; 95% CI, 44.9-100), and amisulpride (85.0%; 95% CI, 68.5-100). Interindividual differences explained most of the variability in occupancy values, besides significant heterogeneity between studies. Dose-occupancy functions estimated the median level of dopamine D₂ receptor occupancy for 8 frequently prescribed antipsychotics in patients with schizophrenia. These dose equivalents can be used to compare antipsychotic effects in epidemiological studies and clinical practice.

1 February 2004 in The American Journal of Tropical Medicine and Hygiene
Verified
Journal Article
Closed access
KRKarin RätH
Karin RätH
KTKatja Taxis
Katja Taxis
GWGitta Walz
Gitta Walz
CGChristoph H. Gleiter
Christoph H. Gleiter
SLShu-Ming Li
Shu-Ming Li
LHLutz Heide
Lutz Heide
Artemisia annua L. (annual wormwood) contains the antimalarial artemisinin. Aqueous preparations of the dried herb are included in the pharmacopoeia of the People’s Republic of China for treatment of fever and malaria. Fourteen healthy male volunteers received one liter of tea prepared from nine grams of Artemisia annua leaves. Blood samples were taken and artemisinin was detected by reversed phase high-performance liquid chromatography. The mean ± SD maximum plasma concentration of artemisinin was 240 ± 75 ng/mL and the mean ± SD area under the plasma concentration-time curve was 336 ± 71 ng/mL × hr. Artemisinin was absorbed faster from herbal tea preparations than from oral solid dosage forms, but bioavailability was similar. One liter of an aqueous preparation of nine grams of Artemisia annua contained 94.5 milligrams of artemisinin (approximately 19% of the usually recommended daily dose). Artemisinin plasma concentrations after intake of this herbal tea are sufficient for clinical effects, but insufficient to recommend such preparations as equivalent substitutes for modern artemisinin drugs in malaria therapy.